PQ signed an agreement to acquire Chem32 for a purchase price of $44 million to complement its refining services business.
Gibbs joined Exxon Company USA in 1993.
This new project, the fifth in a row single-train 60,000 ton/year plant capacity, lifts the total licensed nameplate capacity to 860,000 ton/year.
The company has posted net profit of Rs.151.09 crores for the 12-month period ended December 31, 2020.
The Aemetis Dairy RNG project plan shows revenues growing from $9 million in 2021 to $175 million in 2025.
PVC prices, which are now at Rs129.3/kg, have almost doubled since 1st May'20.
PEL will explore the PLI scheme and apply if its beneficial.
The consortium of Oil India Limited and Engineers India Ltd will acquire 49% and the rest 13.65% will be sold to the Government of Assam.
Rynaxypyr is considered a reduced risk pesticide due to its favourable toxicological and environmental profile.
Linde is one of only two companies recognized in the Chemicals category by the Ethisphere Institute
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
The increased output, cost-effectiveness, seamless operations, and better safety are a few perks of fast-tracking digitalization in the pharma sector
Reflecting on the learning during the pandemic, industry is aiming to push innovation in R&D and implement automation and digital technologies across various operational levels.
Orbia expects EBITDA to increase between 4 to 7%.
The Group’s performance improved in 2H2020 due to China’s rapidly recovering economy and the auto market’s rebound.
Overall core market conditions for all of the businesses are now positive, particularly in Asia.
The transaction is expected to close by the middle of 2021, subject to regulatory and third-party approvals.
ExxonMobil intends to use results from the Baytown trial to scale-up advanced recycling capabilities at other global facilities.
Bayer has announced a series of decisions to accelerate the strategy implementation of its Crop Science division.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio and the transaction is expected to close in the second quarter of 2021
Subscribe To Our Newsletter & Stay Updated
